logo BDSP

Base documentaire

  1. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.

    Article - En anglais

    Context Pharmacist review of medication orders in the intensive care unit (ICU) has been shown to prevent errors, and pharmacist consultation has reduced drug costs.

    However, whether pharmacist participation in the ICU at the time of drug prescribing reduces adverse events has not been studied.

    Objective To measure the effect of pharmacist participation on medical rounds in the ICU on the rate of preventable adverse drug events (ADEs) caused by ordering errors.

    Design Before-after comparison between phase 1 (baseline) and phase 2 (after intervention implemented) and phase 2 comparison with a control unit that did not receive the intervention.

    Setting A medical ICU (study unit) and a coronary care unit (control unit) in a large urban teaching hospital.

    Patients Seventy-five patients randomly selected from each of 3 groups : all admissions to the study unit from February 1,1993, through July 31,1993 (baseline) and all admissions to the study unit (postintervention) and control unit from October 1,1994, through July 7,1995.

    In addition, 50 patients were selected at random from the control unit during the baseline period.

    Intervention A senior pharmacist made rounds with the ICU team and remained in the ICU for consultation in the morning, and was available on call throughout the day.

    Main Outcome Measures Preventable ADEs due to ordering (prescribing) errors and the number, type, and acceptance of interventions made by the pharmacist. (...)

    Mots-clés Pascal : Unité soin intensif, Pharmacien, Pharmacie hospitalière, Prescription médicale, Médicament, Erreur, Intervention, Participation, Equipe soignante, Rôle professionnel, Toxicité, Prévention, Homme

    Mots-clés Pascal anglais : Intensive care unit, Chemist, Hospital pharmacy, Medical prescription, Drug, Error, Operation, Participation, Health care staff, Occupational role, Toxicity, Prevention, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0424304

    Code Inist : 002B30A05. Création : 22/03/2000.